ArticleFrontiers in cell and developmental biology2026

Explainable machine learning for breast mass characterization and malignancy risk stratification: multimodal integration of AI-derived structured digital breast tomosynthesis features and peripheral blood immune-inflammatory biomarkers.

Lu Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.